Development of Chimera AMP–Endolysin with Wider Spectra Against Gram-Negative Bacteria Using High-Throughput Assay
Viruses · 2025
DOI: 10.3390/v17020200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Masato Kogawa und 7 weiteren Autor:innen. Beteiligte Einrichtung: bitBiome, Inc., 513 Wasedatsurumaki-Cho, Shinjuku-Ku 162-0041, Tokyo, Japan. Hauptthemen laut MEDLINE: Endopeptidases, Gram-Negative Bacteria, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Science and Technology Agency, JST FOREST JPMJFR210F.
Abstract (Originalsprache)
Bacteriophage-derived endolysins are being developed as an alternative to antimicrobials. The development of endolysins against Gram-negative bacteria requires the discovery of effective endolysins against the target species and the capability to penetrate the outer membrane of bacteria by endolysin. Here, we propose an efficient endolysin development approach that combines a data-driven endolysin search utilizing bacterial genomes with high-throughput laboratory assays. As a proof of concept, we analyzed endolysin genes detected in 273 bacterial genomes of Acinetobacter, Pseudomonas, and Escherichia. Firstly, we conducted assays of 192 recombinants of endolysin genes obtained through in silico search from bacterial genomes and identified natural endolysins degrading peptidoglycan of Acinetobacter baumannii. Then, we performed high-throughput screening against Gram-negative bacteria for hundreds of chimera AMP–endolysins, natural endolysin conjugated with antimicrobial peptide. As a result, we obtained four chimera AMP–endolysins against A. baumannii, which demonstrated the minimum inhibitory concentration ranging from 4 to 8 μg/mL. Moreover, we assessed the antimicrobial spectra of these chimera AMP–endolysins, validating that two endolysins exhibited antimicrobial efficacy against Pseudomonas aeruginosa and Escherichia coli with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- bitBiome, Inc., 513 Wasedatsurumaki-Cho, Shinjuku-Ku 162-0041, Tokyo, Japan.
- Graduate School of Advanced Science and Engineering, Waseda University, 2-2 Wakamatsu-Cho, Shinjuku-Ku 162-8480, Tokyo, Japan.
- Computational Bio Big-Data Open Innovation Laboratory, National Institute of Advanced Industrial Science and Technology, 3-4-1 Okubo, Shinjuku-Ku 169-8555, Tokyo, Japan.
- Institute for Advanced Research of Biosystem Dynamics, Waseda Research Institute for Science and Engineering, 3-4-1 Okubo, Shinjuku-Ku 169-8555, Tokyo, Japan.
- Research Organization for Nano and Life Innovation, Waseda University, 513 Wasedatsurumaki-Cho, Shinjuku-Ku 162-0041, Tokyo, Japan.
ORCID-Profile: Takuya Yoda, Masahito Hosokawa, Soichiro Tsuda
Förderung
- Japan Science and Technology Agency
- JST FOREST JPMJFR210F
Zitieren
APA
Kogawa, M., Yoda, T., Matsuhashi, A., Matsushita, A., Otsuka, Y., Shibagaki, S., Hosokawa, M., & Tsuda, S. (2025). Development of Chimera AMP–Endolysin with Wider Spectra Against Gram-Negative Bacteria Using High-Throughput Assay. Viruses. https://doi.org/10.3390/v17020200
Vancouver
Kogawa M, Yoda T, Matsuhashi A, Matsushita A, Otsuka Y, Shibagaki S, et al. Development of Chimera AMP–Endolysin with Wider Spectra Against Gram-Negative Bacteria Using High-Throughput Assay. Viruses. 2025. doi:10.3390/v17020200
BibTeX
@article{Kogawa2025,
author = {Kogawa, Masato and Yoda, Takuya and Matsuhashi, Ayumi and Matsushita, Ai and Otsuka, Yoshiki and Shibagaki, Shohei and Hosokawa, Masahito and Tsuda, Soichiro},
title = {Development of Chimera AMP–Endolysin with Wider Spectra Against Gram-Negative Bacteria Using High-Throughput Assay},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17020200}
}
EUVIMED